Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.

Qiu L, Ungerbäck JT, Bennett EP, Bak RO

Open source

DOI
10.1007/s40259-026-00804-x
Published
2026 Sep 14
Container
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40259-026-00804-x,
  title = {Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.},
  author = {Qiu L and Ungerbäck JT and Bennett EP and Bak RO},
  year = {2026},
  journal = {BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy},
  doi = {10.1007/s40259-026-00804-x},
  url = {https://doi.org/10.1007/s40259-026-00804-x}
}

RIS

TY  - JOUR
TI  - Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.
AU  - Qiu L
AU  - Ungerbäck JT
AU  - Bennett EP
AU  - Bak RO
PY  - 2026
JO  - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
DO  - 10.1007/s40259-026-00804-x
UR  - https://doi.org/10.1007/s40259-026-00804-x
ER  - 

APA

L, Q., JT, U., EP, B., & RO, B. (2026). Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases.. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. https://doi.org/10.1007/s40259-026-00804-x

Source records